Barbara Kirschner to Infliximab
This is a "connection" page, showing publications Barbara Kirschner has written about Infliximab.
Connection Strength
0.238
-
Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab. J Pediatr Gastroenterol Nutr. 2012 Jan; 54(1):28-33.
Score: 0.095
-
Timing infliximab therapy in pediatric Crohn's disease. Gastroenterology. 2007 Mar; 132(3):1167-70.
Score: 0.068
-
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. Lancet. 2017 04 29; 389(10080):1710-1718.
Score: 0.034
-
Increased effectiveness of early therapy with anti-tumor necrosis factor-a vs an immunomodulator in children with Crohn's disease. Gastroenterology. 2014 Feb; 146(2):383-91.
Score: 0.027
-
Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium. Inflamm Bowel Dis. 2005 May; 11(5):442-6.
Score: 0.015